Available Until 4/10/2027
View Cart

New Drugs for Kids: 2023 Update

Planned in cooperation with the Section of Pediatrics 

ACPE Activity Number: 0204-0000-24-077-H01-P
Release Date:  April 11, 2024
Expiration Date: April 11, 2027
Activity Type: Knowledge-based 
CE Credits:  1.0 contact hour, (0.10 CEUs)
Activity Fee: Member – Free / Non-Member – Not Available 

This activity is a recording from a live webinar and those that claim credit for the live webinar should not claim credit for this activity.

Activity Overview 

Join experts as they discuss drugs approved by the FDA in 2023 that have uses in pediatric patients. This education will review medication uses and safe medication practices in the pedatric population. 

   
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

Target Audience

This activity was planned to meet the educational needs of all pharmacists who participate in the care of pediatric patients, including pediatric specialists.  

Learning Objectives

After completing this activity, the learner should be able to…

  • Describe 2023 FDA-approved drugs, their uses, and potential pediatric applications.
  • Identify new dosage forms of drugs beneficial for pediatric use.
  • List FDA safety updates from 2023 that are important to clinical practice. 

Schedule of Activities

  • Introduction and Announcements 

  • Presentation  

  • Questions, Answers, and Discussion 

Faculty

Rachel Meyers, PharmD, BCPS, BCPPS, FPPA 

Clinical Professor, Ernest Mario School of Pharmacy, Rutgers University
Pediatric Clinical Pharmacist, Cooperman Barnabas Medical Center
Piscataway, NJ  

Relevant Financial Relationship Disclosure

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

Methods and CE Requirements

This activity consists of recordings of faculty slides presentations, active learning activities, discussion, and handouts. Participants must participate in the activity in its entirety to claim continuing pharmacy education credit online at ASHP Learning Center. Follow the prompts online to complete the evaluation, claim credit and view the statement of credit immediately after completing the activity. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.